Skip to search formSkip to main contentSkip to account menu

Anti-HIV Agents

Known as: Agents, Anti-AIDS, aid drug, Anti AIDS Drugs 
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections… 
National Institutes of Health

Related topics

Related topics

48 relations

Narrower (40)

1,1-azobisformamideAldesleukinAmprenavirDelavirdine
AIDS therapyAntiviral AgentsIn BloodIntegrase

Broader (1)

Pharmaceutical Preparations

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
The Genus Rumex: Review of traditional uses, phytochemistry and pharmacology.
Highly Cited
2014
Highly Cited
2014
Accurate Dereplication of Bioactive Secondary Metabolites from Marine-Derived Fungi by UHPLC-DAD-QTOFMS and a MS/HRMS Library
In drug discovery, reliable and fast dereplication of known compounds is essential for identification of novel bioactive… 
Highly Cited
2012
Highly Cited
2012
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
Background:Obtaining tissue for pancreatic carcinoma diagnosis and biomarker assessment to aid drug development is challenging… 
Review
2007
Review
2007
Drug discovery for malaria: a very challenging and timely endeavor.
  • M. Gelb
  • Current opinion in chemical biology
  • 2007
  • Corpus ID: 21332166
Review
2006
Review
2006
Club drugs and HIV infection: a review.
Club drug use is common among populations with human immunodeficiency virus (HIV) and populations at high risk for HIV infection… 
Review
2005
Review
2005
Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development.
Highly Cited
2004
Highly Cited
2004
Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.
Human C5a is a plasma protein with potent chemoattractant and pro-inflammatory properties, and its overexpression correlates with… 
2003
2003
Interactions of 1263W94 with Other Antiviral Agents in Inhibition of Human Cytomegalovirus Replication
ABSTRACT Inhibition of human cytomegalovirus (HCMV) by 1263W94 was additive dosewise in combination with ganciclovir, acyclovir… 
Highly Cited
2001
Highly Cited
2001
Molecular Interactions of Cyclam and Bicyclam Non-peptide Antagonists with the CXCR4 Chemokine Receptor*
The non-peptide CXCR4 receptor antagonist AMD3100, which is a potent blocker of human immunodeficiency virus cell entry, is a… 
Highly Cited
1993
Highly Cited
1993
Roles for In Vitro Myelotoxicity Tests in Preclinical Drug Development and Clinical Trial Planning
Myelosuppression is the dose-limiting side effect for most anti-cancer and many anti-human immunodeficiency virus agents, which… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License